Challenges in Dengue Vaccines Development: Pre-existing Infections and Cross-Reactivity

by Abdullah M. Izmirly, Abdullah M. Izmirly, Abdullah M. Izmirly, Sana O. Alturki, Sana O. Alturki, Sawsan O. Alturki, Sawsan O. Alturki, Jennifer Connors, Jennifer Connors, Elias K. Haddad, Elias K. Haddad
Published 2020-06-01

The 2020 Pandemic: Current SARS-CoV-2 Vaccine Development

by Sana O. Alturki, Sana O. Alturki, Sawsan O. Alturki, Sawsan O. Alturki, Jennifer Connors, Jennifer Connors, Gina Cusimano, Michele A. Kutzler, Michele A. Kutzler, Abdullah M. Izmirly, Abdullah M. Izmirly, Abdullah M. Izmirly, Elias K. Haddad, Elias K. Haddad
Published 2020-08-01

Non-thermal plasma modulates cellular markers associated with immunogenicity in a model of latent HIV-1 infection.

by Hager Mohamed, Ramona Clemen, Eric Freund, Jan-Wilm Lackmann, Kristian Wende, Jennifer Connors, Elias K Haddad, Will Dampier, Brian Wigdahl, Vandana Miller, Sander Bekeschus, Fred C Krebs
Published 2021-01-01